STOCK TITAN

[6-K] Haleon plc American Current Report (Foreign Issuer)

Filing Impact
(Low)
Filing Sentiment
(Neutral)
Form Type
6-K
Rhea-AI Filing Summary

Haleon plc announced the purchase and cancellation of 175,642 ordinary shares of of each as part of the second tranche of its share buyback programme announced on 31 July 2025. After settlement, Haleonregistered share capital stands at 8,970,696,108 ordinary shares of each, of which 3,880,205 are held as treasury shares, leaving 8,966,815,903 ordinary shares with voting rights. A full breakdown of individual trades is available via the provided link and on the Company's investor website. This announcement relates solely to the executed tranche of the buyback programme and the resulting share capital figures.

Haleon plc ha comunicato l'acquisto e la cancellazione di 175.642 azioni ordinarie di di ciascuna, nell'ambito della seconda tranche del programma di riacquisto di azioni annunciato il 31 luglio 2025. Dopo il regolamento, il capitale sociale registrato di Haleon risulta di 8,970,696,108 azioni ordinarie di ciascuna, di cui 3,880,205 in portafoglio come azioni proprie, lasciando 8,966,815,903 azioni ordinarie con diritto di voto. Un prospetto dettagliato delle singole operazioni è disponibile tramite il link fornito e sul sito investor della Società. Il presente comunicato riguarda esclusivamente la tranche eseguita del programma di riacquisto e le conseguenti cifre del capitale sociale.

Haleon plc ha anunciado la compra y cancelación de 175.642 acciones ordinarias de of cada una, como parte de la segunda tranche de su programa de recompra de acciones anunciado el 31 de julio de 2025. Tras el asentamiento, el capital social registrado de Haleon asciende a 8,970,696,108 acciones ordinarias de cada una, de las cuales 3,880,205 se mantienen como acciones en autocartera, dejando 8,966,815,903 acciones ordinarias con derecho a voto. Un desglose completo de las operaciones individuales está disponible mediante el enlace proporcionado y en la web de inversores de la Compañía. Este anuncio se refiere únicamente a la tranche ejecutada del programa de recompra y a las cifras resultantes del capital social.

Haleon plc는 2025년 7월 31일 발표된 자사주 매입 프로그램의 두 번째 트랜치의 일환으로 각각 의 175,642 보통주를 매입·취소했다고 발표했습니다. 결제 완료 후 Haleon의 등기 발행주식수는 각각 의 8,970,696,108 보통주이며, 그중 3,880,205주는 자기주식으로 보유되어 있어 의결권이 있는 보통주 수는 8,966,815,903주입니다. 개별 거래 내역 전체는 제공된 링크와 회사 투자자 웹사이트에서 확인할 수 있습니다. 이 공지는 매입 프로그램의 실행된 해당 트랜치와 그에 따른 자본 구성 수치에만 관한 것입니다.

Haleon plc a annoncé l'achat et l'annulation de 175 642 actions ordinaires de of chacune, dans le cadre de la deuxième tranche de son programme de rachat d'actions annoncé le 31 juillet 2025. Après règlement, le capital social enregistré de Haleon s'élève à 8,970,696,108 actions ordinaires de chacune, dont 3,880,205 sont détenues en actions propres, laissant 8,966,815,903 actions ordinaires avec droit de vote. Une ventilation complète des transactions individuelles est disponible via le lien fourni et sur le site investisseurs de la Société. Cette annonce concerne uniquement la tranche exécutée du programme de rachat et les chiffres du capital social qui en résultent.

Haleon plc hat den Erwerb und die Löschung von 175.642 Stammaktien zu je of angekündigt, als Teil der zweiten Tranche ihres am 31. Juli 2025 bekanntgegebenen Aktienrückkaufprogramms. Nach Abwicklung beträgt das eingetragene Grundkapital von Haleon 8,970,696,108 Stammaktien zu je , hiervon werden 3,880,205 als eigene Aktien gehalten, sodass 8,966,815,903 stimmberechtigte Stammaktien verbleiben. Eine vollständige Aufschlüsselung der einzelnen Transaktionen ist über den bereitgestellten Link und auf der Investorenseite des Unternehmens verfügbar. Diese Mitteilung bezieht sich ausschließlich auf die ausgeführte Tranche des Rückkaufprogramms und die daraus resultierenden Kapitalangaben.

Positive
  • None.
Negative
  • None.

Insights

TL;DR: Executed a small tranche of the announced buyback; share capital and voting figures updated.

Haleon completed the purchase and cancellation of 175,642 ordinary shares under the second tranche of its buyback programme. The transaction reduced issued shares and increased treasury share holdings to 3,880,205, leaving 8,966,815,903 shares with voting rights. The notice provides a trade breakdown link but contains no financial impact metrics such as cash spent relative to market cap or percentage of programme completed. Given the absolute size versus total issued shares, this tranche appears operationally routine rather than material to earnings or leverage.

TL;DR: Buyback executed and cancelled; updated voting share count for disclosure compliance.

The announcement documents compliance with disclosure rules by reporting the cancellation and the updated voting share count that determines shareholders' notification thresholds under the FCA rules. It also references the Market Abuse Regulation trade breakdown. The filing is procedural and ensures accurate public registers and transparency; it contains no commentary on intent, timing of further tranches, or funding source.

Haleon plc ha comunicato l'acquisto e la cancellazione di 175.642 azioni ordinarie di di ciascuna, nell'ambito della seconda tranche del programma di riacquisto di azioni annunciato il 31 luglio 2025. Dopo il regolamento, il capitale sociale registrato di Haleon risulta di 8,970,696,108 azioni ordinarie di ciascuna, di cui 3,880,205 in portafoglio come azioni proprie, lasciando 8,966,815,903 azioni ordinarie con diritto di voto. Un prospetto dettagliato delle singole operazioni è disponibile tramite il link fornito e sul sito investor della Società. Il presente comunicato riguarda esclusivamente la tranche eseguita del programma di riacquisto e le conseguenti cifre del capitale sociale.

Haleon plc ha anunciado la compra y cancelación de 175.642 acciones ordinarias de of cada una, como parte de la segunda tranche de su programa de recompra de acciones anunciado el 31 de julio de 2025. Tras el asentamiento, el capital social registrado de Haleon asciende a 8,970,696,108 acciones ordinarias de cada una, de las cuales 3,880,205 se mantienen como acciones en autocartera, dejando 8,966,815,903 acciones ordinarias con derecho a voto. Un desglose completo de las operaciones individuales está disponible mediante el enlace proporcionado y en la web de inversores de la Compañía. Este anuncio se refiere únicamente a la tranche ejecutada del programa de recompra y a las cifras resultantes del capital social.

Haleon plc는 2025년 7월 31일 발표된 자사주 매입 프로그램의 두 번째 트랜치의 일환으로 각각 의 175,642 보통주를 매입·취소했다고 발표했습니다. 결제 완료 후 Haleon의 등기 발행주식수는 각각 의 8,970,696,108 보통주이며, 그중 3,880,205주는 자기주식으로 보유되어 있어 의결권이 있는 보통주 수는 8,966,815,903주입니다. 개별 거래 내역 전체는 제공된 링크와 회사 투자자 웹사이트에서 확인할 수 있습니다. 이 공지는 매입 프로그램의 실행된 해당 트랜치와 그에 따른 자본 구성 수치에만 관한 것입니다.

Haleon plc a annoncé l'achat et l'annulation de 175 642 actions ordinaires de of chacune, dans le cadre de la deuxième tranche de son programme de rachat d'actions annoncé le 31 juillet 2025. Après règlement, le capital social enregistré de Haleon s'élève à 8,970,696,108 actions ordinaires de chacune, dont 3,880,205 sont détenues en actions propres, laissant 8,966,815,903 actions ordinaires avec droit de vote. Une ventilation complète des transactions individuelles est disponible via le lien fourni et sur le site investisseurs de la Société. Cette annonce concerne uniquement la tranche exécutée du programme de rachat et les chiffres du capital social qui en résultent.

Haleon plc hat den Erwerb und die Löschung von 175.642 Stammaktien zu je of angekündigt, als Teil der zweiten Tranche ihres am 31. Juli 2025 bekanntgegebenen Aktienrückkaufprogramms. Nach Abwicklung beträgt das eingetragene Grundkapital von Haleon 8,970,696,108 Stammaktien zu je , hiervon werden 3,880,205 als eigene Aktien gehalten, sodass 8,966,815,903 stimmberechtigte Stammaktien verbleiben. Eine vollständige Aufschlüsselung der einzelnen Transaktionen ist über den bereitgestellten Link und auf der Investorenseite des Unternehmens verfügbar. Diese Mitteilung bezieht sich ausschließlich auf die ausgeführte Tranche des Rückkaufprogramms und die daraus resultierenden Kapitalangaben.

UNITED STATES
 
SECURITIES AND EXCHANGE COMMISSION
 
Washington, D.C. 20549
 
 
FORM 6-K
 
REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934
 
For the month of August 2025
 
Commission File Number: 001-41411
 
Haleon plc
(Translation of registrant’s name into English)
 
Building 5, First Floor, The Heights,
Weybridge, Surrey, KT13 0NY
(Address of principal executive offices)
 
 
Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F:
 
 
Form 20-F
 
Form 40-F
 
 
 
EXHIBIT INDEX
 
Exhibit Number
Description
        99.1
22 August 2025 - “Transaction in Own Shares”
 
 
 
 
99.1
 
 
Haleon plc: Transaction in own shares
 
22 August 2025: Haleon plc (the "Company" or "Haleon") today announces the purchase of 175,642 ordinary shares of £0.01 each in the Company (the "Shares") for cancellation under the second tranche of its share buyback programme announced on 31 July 2025.
 
 
London Stock Exchange
CBOE (UK)/BXE
CBOE (UK)/CXE
Date of purchase:
21 August 2025
21 August 2025
21 August 2025
Number of Shares purchased:
175,642
-
-
Highest price paid per Share (p):
366.0000
-
-
Lowest price paid per Share (p):
365.1000
-
-
Volume weighted average price paid per Share (p):
365.6259
-
-
 
Following the settlement of the above, the Company's registered share capital is 8,970,696,108 ordinary shares of £0.01 each, of which 3,880,205 are held as treasury shares. Therefore, the number of ordinary shares with voting rights is 8,966,815,903 and this figure may be used by shareholders to determine if they are required to notify their interest, or a change to their interest, in Haleon under the FCA's Disclosure Guidance and Transparency Rules.
 
In accordance with Article 5(1)(b) of Regulation (EU) No 596/2014 as it applies in the UK (the Market Abuse Regulation), a full breakdown of the individual trades is available at the link below:
 
http://www.rns-pdf.londonstockexchange.com/rns/3368W_1-2025-8-21.pdf
 
This announcement does not constitute, or form part of, an offer or any solicitation of an offer for securities in any jurisdiction.
 
This announcement and individual trade breakdown will also be available on the Company's website at: www.haleon.com/investors.
 
Enquiries
 
 
Investors
Media
 
Jo Russell  
+44 7787 392441
Zoë Bird
+44 7736 746167
Rakesh Patel     
+44 7552 484646
Victoria Durman
+44 7894 505730
Email: investor-relations@haleon.com
Email: corporate.media@haleon.com
 
About Haleon
Haleon (LSE/NYSE: HLN) is a global leader in consumer health, with a purpose to deliver better everyday health with humanity. Haleon's product portfolio spans six major categories - Oral Health, Vitamins, Minerals and Supplements (VMS), Pain Relief, Respiratory Health, Digestive Health and Therapeutic Skin Health and Other. Its long-standing brands - such as Advil, Centrum, Otrivin, Panadol, parodontax, Polident, Sensodyne, Theraflu and Voltaren - are built on trusted science, innovation and deep human understanding.
 
For more information, please visit www.haleon.com
 
 
SIGNATURE
 
 
 
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.
 
 
 
HALEON PLC
(Registrant)
 
Date: August 22, 2025
By:
/s/ Amanda Mellor
 
 
Name:
Amanda Mellor
 
 
Title:
Company Secretary
Haleon

NYSE:HLN

HLN Rankings

HLN Latest News

HLN Latest SEC Filings

HLN Stock Data

44.44B
4.49B
0.02%
12.82%
0.39%
Drug Manufacturers - Specialty & Generic
Healthcare
Link
United Kingdom
Weybridge